#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA615352	B	Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome	Homo sapiens	19	ALA1136019	subcellular format	Scientific Literature
2.	ALA615353	B	Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain	Homo sapiens	7	ALA1128409	subcellular format	Scientific Literature
3.	ALA834792	F	Inhibitory concentration to inhibit trypsin-like activity of 20S proteasome from human leukemia HL-60 cells was determined	Homo sapiens	13	ALA1143504	subcellular format	Scientific Literature
4.	ALA837922	F	Inhibitory concentration to inhibit the PGPH activity of 20S proteasome prepared from human leukemia HL-60 cells was determined	Homo sapiens	13	ALA1143504	subcellular format	Scientific Literature
5.	ALA874816	F	Inhibitory concentration to inhibit chymotrypsin-like activity of 20S proteasome prepared from human leukemia HL-60 cells was determined	Homo sapiens	13	ALA1143504	subcellular format	Scientific Literature
6.	ALA909078	B	Inhibition of human 20S proteasome	Homo sapiens	8	ALA1141377	subcellular format	Scientific Literature
7.	ALA4199261	B	Inhibition of 20S proteasome activity in human ANBL-6 cells	Homo sapiens	1	ALA4196096	cell-based format	Scientific Literature
8.	ALA4357205	B	Inhibition of human 20S proteasome using Suc-LLVY-AMC as substrate measured every 5 mins for 120 mins by fluorescence based assay	Homo sapiens	5	ALA4354831	protein complex format	Scientific Literature
9.	ALA4357206	B	Inhibition of 20S proteasome in human HeLa cells at 2xIC50 using LLVY-R110 peptide as substrate measured up to 36 hrs by fluorescence based assay	Homo sapiens	2	ALA4354831	cell-based format	Scientific Literature
10.	ALA4357207	B	Inhibition of 20S proteasome in human BE(2)-C cells at 2xIC50 using LLVY-R110 peptide as substrate measured up to 36 hrs by fluorescence based assay	Homo sapiens	2	ALA4354831	cell-based format	Scientific Literature
11.	ALA4357208	B	Potency index, ratio of ixazomib IC50 to compound IC50 for inhibition of human 20S proteasome using Suc-LLVY-AMC as substrate measured every 5 mins for 120 mins by fluorescence based assay	Homo sapiens	2	ALA4354831	protein complex format	Scientific Literature
12.	ALA4371818	B	Negative allosteric modulation of SDS-activated human erythrocytes 20S proteasome assessed as reduction in human alpha-synuclein degradation at 1 uM after 1 hr by SDS-PAGE analysis	Homo sapiens	4	ALA4371016	assay format	Scientific Literature
13.	ALA4371819	B	Negative allosteric modulation of SDS-activated human erythrocytes 20S proteasome assessed as reduction in human alpha-synuclein degradation at 10 uM after 1 hr by SDS-PAGE analysis	Homo sapiens	7	ALA4371016	assay format	Scientific Literature
14.	ALA4371820	B	Negative allosteric modulation of SDS-activated human erythrocytes 20S proteasome assessed as reduction in yeast enolase degradation at 1 uM after 1 hr by SDS-PAGE analysis	Homo sapiens	5	ALA4371016	assay format	Scientific Literature
15.	ALA4371821	B	Negative allosteric modulation of SDS-activated human erythrocytes 20S proteasome assessed as reduction in yeast enolase degradation at 10 uM after 1 hr by SDS-PAGE analysis	Homo sapiens	5	ALA4371016	assay format	Scientific Literature
16.	ALA4371822	B	Positive allosteric modulation of SDS-activated human erythrocytes 20S proteasome assessed as increase in yeast enolase degradation at 1 uM after 1 hr by SDS-PAGE analysis relative to control	Homo sapiens	2	ALA4371016	assay format	Scientific Literature
17.	ALA4371826	B	Effect on alpha-face conformations of latent human erythrocytes 20S proteasome assessed as open state conformation at 1 uM by atomic force microscopic method (Rvb = 7%)	Homo sapiens	2	ALA4371016	assay format	Scientific Literature
18.	ALA4371827	B	Effect on alpha-face conformations of latent human erythrocytes 20S proteasome assessed as intermediate state conformation at 1 uM by atomic force microscopic method (Rvb = 22%)	Homo sapiens	1	ALA4371016	assay format	Scientific Literature
19.	ALA4371828	B	Effect on alpha-face conformations of latent human erythrocytes 20S proteasome assessed as open state conformation at 10 uM by atomic force microscopic method (Rvb = 7%)	Homo sapiens	1	ALA4371016	assay format	Scientific Literature
20.	ALA4371829	B	Effect on alpha-face conformations of latent human erythrocytes 20S proteasome assessed as intermediate state conformation at 10 uM by atomic force microscopic method (Rvb = 22%)	Homo sapiens	1	ALA4371016	assay format	Scientific Literature